---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-016054"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2023-05-01T23:59:59+00:00"
generated_at: "2026-06-16T05:13:18.446838+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Tivic Health appoints interim CFO Kimberly Bambach, strategic advisor Christina Valauri; CFO Veronica Cai resigns

## Summary
- CFO Veronica Cai resigned effective April 28, 2023; receives $125K lump sum upon signing release.
- Kimberly Bambach appointed interim CFO, paid $200/hour as non-employee consultant.
- Christina Valauri engaged as strategic advisor to board; former healthcare analyst at Cantor Fitzgerald.
- Cai stated resignation not due to any disagreement with company's operations or policies.
- Bambach brings 30+ years financial leadership; previously CFO of Jushi Holdings.

## SEC filing metadata
- accession: 0000950170-23-016054
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2023-05-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000095017023016054/0000950170-23-016054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000095017023016054/tivc-20230428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-016054
- JSON: https://secwatch.observer/filing/0000950170-23-016054.json
- Plain text: https://secwatch.observer/filing/0000950170-23-016054.txt

## Key facts
- Executive change
  Kimberly Bambach was appointed as interim Chief Financial Officer and Principal Financial and Principal Accounting Officer at Valion Bio, Inc..
  - Action: appointed
  - Role: interim Chief Financial Officer and Principal Financial and Principal Accounting Officer
  source text: Effective April 28, 2023, Kimberly Bambach was appointed as the Company’s new interim Chief Financial Officer and Principal Financial and Principal Accounting Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787740/000095017023016054/0000950170-23-016054-index.htm
- Executive change
  Veronica Cai resigned as Chief Financial Officer at Valion Bio, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On April 28, 2023, Veronica Cai resigned from her role as Chief Financial Officer of Tivic Health Systems, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787740/000095017023016054/0000950170-23-016054-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.